Stock 4539 NIPPON CHEMIPHAR CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Nippon Chemiphar Co., Ltd.

Equities

4539

JP3701600003

Pharmaceuticals

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-04-26 am EDT 		5-day change 1st Jan Change
1,590 JPY -1.36% Intraday chart for Nippon Chemiphar Co., Ltd. -0.69% +1.86%
2023 Delta-Fly Pharma, Inc. announced that it has received ¥503.7238 million in funding from Nippon Chemiphar Co., Ltd. CI
2023 Global EV battery supply chain puzzles over China graphite curbs RE

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 17,193 10,520 8,898 9,455 7,524 6,637
Enterprise Value (EV) 1 24,235 16,812 13,918 14,238 10,667 11,338
P/E ratio 15 x 11.9 x 20.4 x 19.1 x 10.7 x 19.6 x
Yield 2.12% 3.42% 2.02% 1.9% 2.4% 2.72%
Capitalization / Revenue 0.49 x 0.31 x 0.28 x 0.3 x 0.23 x 0.21 x
EV / Revenue 0.69 x 0.49 x 0.44 x 0.45 x 0.33 x 0.36 x
EV / EBITDA 7.97 x 5.98 x 8.5 x 7.27 x 4.42 x 9 x
EV / FCF 40 x 13.4 x 16.3 x 152 x 6.69 x -4.28 x
FCF Yield 2.5% 7.47% 6.14% 0.66% 15% -23.3%
Price to Book 0.97 x 0.59 x 0.51 x 0.52 x 0.41 x 0.36 x
Nbr of stocks (in thousands) 3,639 3,595 3,595 3,595 3,610 3,609
Reference price 2 4,725 2,926 2,475 2,630 2,084 1,839
Announcement Date 6/25/18 6/24/19 6/22/20 6/21/21 6/27/22 6/22/23
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 35,331 34,182 31,756 31,541 32,506 31,559
EBITDA 1 3,041 2,809 1,637 1,958 2,412 1,260
EBIT 1 1,849 1,464 365 565 826 -240
Operating Margin 5.23% 4.28% 1.15% 1.79% 2.54% -0.76%
Earnings before Tax (EBT) 1 1,776 1,453 732 713 975 480
Net income 1 1,160 881 436 495 700 339
Net margin 3.28% 2.58% 1.37% 1.57% 2.15% 1.07%
EPS 2 315.2 245.0 121.3 137.7 194.1 93.92
Free Cash Flow 1 605.5 1,256 854.6 93.88 1,596 -2,646
FCF margin 1.71% 3.68% 2.69% 0.3% 4.91% -8.39%
FCF Conversion (EBITDA) 19.91% 44.73% 52.21% 4.79% 66.15% -
FCF Conversion (Net income) 52.2% 142.61% 196.01% 18.96% 227.93% -
Dividend per Share 2 100.0 100.0 50.00 50.00 50.00 50.00
Announcement Date 6/25/18 6/24/19 6/22/20 6/21/21 6/27/22 6/22/23
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2020 S1 2021 S1 2022 S1 2022 Q3 2023 Q1 2023 S1 2023 Q3 2024 Q1 2024 S1 2024 Q3
Net sales 1 16,097 14,832 15,575 9,152 8,425 16,237 7,778 7,537 14,837 8,232
EBITDA - - - - - - - - - -
EBIT 1 619 -189 206 893 175 167 25 -106 -298 262
Operating Margin 3.85% -1.27% 1.32% 9.76% 2.08% 1.03% 0.32% -1.41% -2.01% 3.18%
Earnings before Tax (EBT) 1 513 -346 258 1,021 925 1,164 -193 111 27 115
Net income 1 326 -257 228 724 653 896 -212 79 31 73
Net margin 2.03% -1.73% 1.46% 7.91% 7.75% 5.52% -2.73% 1.05% 0.21% 0.89%
EPS 2 90.83 -71.60 63.56 200.6 180.9 248.4 -58.81 22.03 8.720 20.17
Dividend per Share - - - - - - - - - -
Announcement Date 10/31/19 10/30/20 10/29/21 1/31/22 7/29/22 10/31/22 1/31/23 7/31/23 10/31/23 1/31/24
1JPY in Million2JPY
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 7,042 6,292 5,020 4,783 3,143 4,701
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 2.316 x 2.24 x 3.067 x 2.443 x 1.303 x 3.731 x
Free Cash Flow 1 606 1,256 855 93.9 1,596 -2,646
ROE (net income / shareholders' equity) 6.66% 4.98% 2.47% 2.8% 3.83% 1.83%
ROA (Net income/ Total Assets) 2.46% 1.95% 0.49% 0.76% 1.07% -0.31%
Assets 1 47,087 45,129 88,672 65,174 65,482 -110,784
Book Value Per Share 2 4,863 4,968 4,838 5,011 5,125 5,135
Cash Flow per Share 2 2,216 2,596 2,804 2,944 3,226 2,917
Capex 1 2,041 877 449 381 725 1,005
Capex / Sales 5.78% 2.57% 1.41% 1.21% 2.23% 3.18%
Announcement Date 6/25/18 6/24/19 6/22/20 6/21/21 6/27/22 6/22/23
1JPY in Million2JPY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
NIPPON CHEMIPHAR CO., LTD. Stock Nippon Chemiphar Co., Ltd.
+1.86% 36.89M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.76% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.77% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.69% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.26% 332B
ABBVIE INC. Stock AbbVie Inc.
+2.45% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.60% 231B
NOVARTIS AG Stock Novartis AG
+4.80% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.37% 195B
AMGEN INC. Stock Amgen Inc.
-5.34% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 4539 Stock
  4. Financials Nippon Chemiphar Co., Ltd.